Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Takeda
1221
Takeda
Health Care
Medical
Pharmaceuticals
Takeda Pharmaceutical Company Limited
Suggest edits
Type
B2b
Follow us
Companies in the same industry
TwelveStone Health
TransEnterix
Spruce Biosciences
C2i Genomics
VentiRx Pharmaceuticals
Pharmly
Avisa Pharma
SkyQuest Technology Consulting Private Limited
Strongbridge Biopharma
Orca Pharmaceuticals
Alexa global traffic share
Twitter followers
Overview
Investments
2
Acquisitions
2
Add info
Team Size
1–10
Employees
I work here
Location
Japan
Headquarters
Explore Japan
neurons.AI
FiercePharmaAsia—Sinopharm, Sinovac COVID vaccines; Takeda’s warning letter, $2B pipeline cull
neurons.AI
Neurocrine picks Takeda’s brain
neurons.AI
Takeda licences psychiatry programmes to Neurocrine Biosciences
DealStreetAsia
Japan’s Takeda plans to sell consumer health unit for around $3.7b
MedCity News
Takeda’s oral multiple myeloma drug narrowly misses in Phase III study
the home of AI info
Charles River, Takeda Enter Drug Discovery Alliance
the home of AI info
Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical ...
the home of AI info
MIT, Takeda Partner to Develop Healthcare Artificial Intelligence
the home of AI info
MIT, Takeda Partner to Develop Healthcare Artificial Intelligence
Xconomy
Takeda to Fund AI Projects at MIT as Part of New 3-Year Collaboration
the home of AI info
MIT School of Engineering and Takeda join to advance research in artificial intelligence and health
SiliconRepublic
Takeda announces second year of UCD biopharma scholarship
PrivateEquityWire
Nordic Capital-backed Acino to acquire Takeda primary care portfolio in key emerging markets
Xconomy
Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center
Reuters Top News
Undeterred by Sanofi's stumble, Takeda takes similar path with...
Reuters Top News
JOC head Takeda: no improper actions such as bribery in Tokyo 2020 bid
Bloomberg
Takeda and Shire Have a $60 Billion Drug Problem
Strategy
Health
Bloomberg
Takeda CEO Sees Path to Survival in Shire Megadeal
Health
Strategy
Bloomberg
Takeda Shareholders Should Come Around to Shire
Health
Stock markets
Earnings
Xconomy
,
Bloomberg
Takeda Strikes $62B Deal to Acquire Rare Disease Drug Maker Shire
Strategy
Health
